JPI Healthcare Co.,Ltd. (KOSDAQ:0010V0)
South Korea · Delayed Price · Currency is KRW 8,860.00
-140.00 (-1.56%)
At close: Aug 24, 2026
JPI Healthcare Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | 5,466 | 5,258 | 6,036 | 6,608 |
Depreciation & Amortization | 1,569 | 1,525 | 1,594 | 1,562 |
Loss (Gain) From Sale of Assets | -15.91 | -0.3 | 2.91 | 54.9 |
Loss (Gain) From Sale of Investments | -405.75 | -505.75 | -167.69 | -971.94 |
Stock-Based Compensation | 288.06 | 214.44 | - | - |
Provision & Write-off of Bad Debts | 226.43 | 209.27 | 196.71 | -439.62 |
Other Operating Activities | -725.87 | 358.34 | -425.31 | 736.48 |
Change in Accounts Receivable | -792.56 | -1,337 | -223.29 | -1,656 |
Change in Inventory | 289.27 | -525.26 | -2,885 | -1,986 |
Change in Accounts Payable | -1,225 | -1,048 | 625.49 | 966.88 |
Change in Unearned Revenue | 21.03 | 11.69 | -67.83 | 66.19 |
Change in Other Net Operating Assets | -316.54 | -943.75 | -783.93 | -526.57 |
Operating Cash Flow | 4,378 | 3,217 | 3,902 | 4,414 |
Operating Cash Flow Growth | 20.27% | -17.56% | -11.59% | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -1,667 | -1,131 | -10,885 | -704.26 |
Sale of Property, Plant & Equipment | 14.59 | 2.25 | 7.38 | 0.1 |
Sale (Purchase) of Intangibles | -537.31 | -37.59 | -413.3 | -49.99 |
Investment in Securities | -14,419 | -15,263 | 3,229 | -861.29 |
Other Investing Activities | 15.31 | 35.52 | 201.6 | -84.13 |
Investing Cash Flow | -16,599 | -16,404 | -7,860 | -1,698 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Short-Term Debt Issued | - | 609.96 | 987.56 | 1,000 |
Long-Term Debt Issued | - | 5,000 | 8,460 | - |
Total Debt Issued | 35.6 | 5,610 | 9,448 | 1,000 |
Short-Term Debt Repaid | - | -6,489 | -2,100 | -2,000 |
Long-Term Debt Repaid | - | -3,577 | -514.44 | -516.77 |
Total Debt Repaid | -4,527 | -10,066 | -2,614 | -2,517 |
Net Debt Issued (Repaid) | -4,491 | -4,456 | 6,833 | -1,517 |
Issuance of Common Stock | 17,950 | 17,950 | - | - |
Dividends Paid | - | -1,437 | -1,455 | -1,123 |
Other Financing Activities | -0 | -0 | -0 | - |
Financing Cash Flow | 13,459 | 12,057 | 5,378 | -2,639 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Foreign Exchange Rate Adjustments | -123.28 | 18.18 | 213.96 | -57.97 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | -0 |
Net Cash Flow | 1,115 | -1,112 | 1,634 | 18.03 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | 2,711 | 2,086 | -6,982 | 3,710 |
Free Cash Flow Growth | - | - | - | - |
Free Cash Flow Margin | 5.65% | 4.30% | -15.50% | 8.17% |
Free Cash Flow Per Share | 571.14 | 463.20 | -1679.24 | 892.14 |
Levered Free Cash Flow | 1,448 | 767.64 | -10,908 | - |
Unlevered Free Cash Flow | 1,673 | 1,022 | -10,656 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 359.31 | 417.89 | 403.2 | 335.1 |
Cash Income Tax Paid | 966.9 | 719.55 | 862.75 | 1,451 |
Change in Working Capital | -2,023 | -3,842 | -3,334 | -3,136 |